On Tuesday 11/14, an awareness talk was held by Biochemist Javier Marx Mgter in Public Health and University Professor, referring to prostate cancer at the Puerto Iguazú Volunteer Fire Department.
According to studies, prostate cancer is the leading cause of death in men over 60 years of age and with the highest incidence in men in Argentina, each year some 3,700 cases are detected. Its mortality has been decreasing by 4% per year.
Oncological mortality statistics indicate the main types of cancer among men and women in 2013. In the case of men, lung cancer is in first place with 8,094 cases and prostate cancer in 2nd place with 5,038. cases. In women, breast cancer ranks first with 6,578 cases and colorectal cancer ranks second with 4,522 cases.
As soon as the Biochemist Javier Marx mentioned to us that all men over 40 years of age or with a family history should be controlled. “This is a specific prostate antigen blood test, and it can be done at the Samic Puerto Iguazú Hospital. It is not necessary to take an appointment or have a medical order, just show up with a photocopy of your ID if you do not have social work, the exam is free, and it is important not to perform physical activity before the analysis, “said Javier Marx.
With respect to the diagnosis, it is carried out through the determination of PSA, digital rectal examination and diagnostic imaging Pathological studies. Regarding the prognosis: It is a type of cancer that can be treated with less aggressive treatments than chemotherapy. Much of the treatment is done with antihormonals. There are also new highly focused and highly curative radiotherapies. The prognosis is usually better than other types of cancer, if it is diagnosed early, it has a high chance of being cured.
Regarding the diagnostic sequence, all SYMPTOMATIC patients must be studied. Of all ASYMPTOMATIC patients who attend the consultation requesting to be studied. Those aged 40 to 49 years and with a family history of risk. Men between 50 and 75 years of age and those over 75 without significant comorbidities that limit their life expectancy. Screening is not recommended in asymptomatic patients under 50 years of age with no family history. Screening is also not recommended in patients older than 75 years with less than 10 years of life expectancy due to severe comorbidities, as it is more harmful than beneficial. With a life expectancy of more than 10 years, they are asked the pros and cons of screening to reach an informed decision.